CAMBRIDGE, Mass., July 21, 2017 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Thursday, August 3, 2017, at
4:30 p.m. ET to review its second
quarter 2017 financial results and provide an update on the
company.
A live webcast of the conference call can be accessed in the
Investors/Media section of Infinity's website at www.infi.com. To
participate in the conference call, please dial 1-877-316-5293
(domestic) and 1-631-291-4526 (international) five minutes prior to
start time. The conference ID number is 40376609. An archived
version of the webcast will be available on Infinity's website for
30 days.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1 study in patients with advanced solid tumors
is ongoing. For more information on Infinity, please refer to
Infinity's website at www.infi.com.
Contact:
Jaren Irene
Madden, Senior Director,
Investor Relations and Corporate Communications
Jaren.Madden@infi.com
View original
content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2017-financial-results-conference-call-and-webcast-300491966.html
SOURCE Infinity Pharmaceuticals, Inc.